Evidence map›Paper›PMID 23045536›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2012

The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests?

Electra D Paskett, Mira L Katz, Douglas M Post, Michael L Pennell, Gregory S Young, Eric E Seiber, J Phil Harrop, Cecilia R DeGraffinreid, Cathy M Tatum, Julie A Dean and 2 more

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 8 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 8 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Adherence in the Cancer Care Setting: a Systematic Review of Patient Navigation to Traverse Barriers.Journal of cancer education : the official journal of the American Association for Cancer Education · 2018
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Clinic type and patient characteristics affecting time to resolution after an abnormal cancer-screening exam.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Trial
  15. Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Trial
  16. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2014
    Trial
  17. Trial
  18. Trial
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Electra D PaskettDivision of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio 43201, USA. Electra.Paskett@osumc.edu
Mira L Katz
Douglas M Post
Michael L Pennell
Gregory S Young
Eric E Seiber
J Phil Harrop
Cecilia R DeGraffinreid
Cathy M Tatum
Julie A Dean
David M Murray
Ohio Patient Navigation Research Program
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI WANCAI YANG · 1985 to 2026
$132.3M
University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
The Ohio State University Center for Clinical and Translational Science (KL2)KL2RR025754 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$3.5M
The Ohio State University Center for Clinical and Translational Science (TL1)TL1RR025753 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$1.4M
The Ohio State University Center for Clinical and Translational Science (KL2)KL2TR000112 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$855k
The Ohio State University Center for Clinical and Translational Science (TL1)TL1TR000091 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$384k
NCATS NIH HHS 8KL2TR000112-05NCATS NIH HHS 8TL1TR000091-05NCATS NIH HHS 8UL1TR000090-05NCATS NIH HHS KL2 TR000112NCATS NIH HHS TL1 TR000091NCATS NIH HHS UL1 TR000090NCI NIH HHS P30 CA016058NCI NIH HHS P30CA016058NCRR NIH HHS KL2 RR025754NCRR NIH HHS KL2RR025754NCRR NIH HHS TL1 RR025753NCRR NIH HHS TL1RR025753NCRR NIH HHS UL1 RR025755NCRR NIH HHS UL1RR025755
6 · The paper itself

Abstract

backgroundPatient navigation (PN) has been suggested as a way to reduce cancer health disparities; however, many models of PN exist and most have not been carefully evaluated. The goal of this study was to test the Ohio American Cancer Society model of PN as it relates to reducing time to diagnostic resolution among persons with abnormal breast, cervical, or colorectal cancer screening tests or symptoms.

methodsA total of 862 patients from 18 clinics participated in this group-randomized trial. Chart review documented the date of the abnormality and the date of resolution. The primary analysis used shared frailty models to test for the effect of PN on time to resolution. Crude HR were reported as there was no evidence of confounding.

resultsHRs became significant at 6 months; conditional on the random clinic effect, the resolution rate at 15 months was 65% higher in the PN arm (P = 0.012 for difference in resolution rate across arms; P = 0.009 for an increase in the HR over time).

conclusionsParticipants with abnormal cancer screening tests or symptoms resolved faster if assigned to PN compared with those not assigned to PN. The effect of PN became apparent beginning six months after detection of the abnormality. IMPACT: PN may help address health disparities by reducing time to resolution after an abnormal cancer screening test.

Indexed as

Early Detection of CancerPatient NavigationAdultAgedAged, 80 and overAmerican Cancer SocietyBreast NeoplasmsColorectal NeoplasmsFemaleHealthcare DisparitiesHumansMaleMiddle AgedOhioSocial SupportTime Factors

Identifiers

PMID23045536
PMCPMC3785236
OpenAlexW2102805862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.